Quantum Genesis AI (QGAI) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 121 155 sessions, February 17, 2026 to November 5, 2026
- Largest daily move
- +461.1% close of May 22, 2026
- 1-month change
- -78.2% closing prices, October 5, 2026 to November 5, 2026
Company Description
Quantum Genesis AI (OTC: QGAI) is classified in the specialty chemicals industry within the Basic Materials sector and carries a market capitalization of $495.8K.
QGAI has declined 78.2% over the past month. The last closing price was $0.0300.
For FY2025, Quantum Genesis AI reported revenue of $0 and diluted earnings per share of -$0.01.
This page collects what Stock Titan holds for QGAI, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
Quantum Genesis AI (QGAI) closed at $0.0300 on November 5, 2026. Over the past month, the price has lost 78.2%.
QGAI Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Quantum Genesis AI has filed 10 recent SEC filings, including 2 Form 1-A/A, 2 Form 10-Q, 2 Form 10-Q/A, 1 Form NT 10-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all QGAI SEC filings →
Financial Highlights
Quantum Genesis AI reported diluted earnings per share of -$0.01 in FY2025. The current ratio was 0.00, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Quantum Genesis AI (QGAI) currently stands at 849 shares, representing 0.0% of the float. Since February 2026, short interest has decreased by 81.3%.
Days to Cover History
Days to cover for Quantum Genesis AI (QGAI) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
QGAI Company Profile & Sector Positioning
Quantum Genesis AI (QGAI) operates in the Specialty Chemicals industry within the broader Basic Materials sector and is listed on the OTC.
Investors comparing QGAI often look at related companies in the same sector, including FendX Technologies Inc (FDXTF), Premier Biomedical Inc (BIEI), Hydromer Inc (HYDI), NOHO Inc (DRNK), and Industrial Nanotech Inc (INTK). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate QGAI's relative position within its industry.